Sealantium’s First Pivotal Phase 1/2 Trial Published in the American Journal of Surgery

Sealantium Medical is proud to announce the publication of its first pivotal Phase 1/2 randomized controlled multicenter trial in the peer-reviewed American Journal of Surgery. This landmark study compared sFilm-FS™, Sealantium’s dual-acting fibrin sealant patch, with Tachosil®, a leading hemostatic agent, in elective liver surgery. The results highlight a significant advance in surgical biomaterials: These […]